AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 19 filers reported holding AC IMMUNE SA in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $262,000 | – | 15,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,428,379 | $21,170,880 | 0.57% |
| Avidity Partners Management LP | 2,969,800 | $8,463,930 | 0.34% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,322,462 | $3,769,017 | 0.15% |
| Eversept Partners, LP | 124,589 | $355,079 | 0.03% |
| COHEN LAWRENCE B | 12,850 | $36,623 | 0.02% |
| Banque Cantonale Vaudoise | 80,701 | $231 | 0.01% |
| Renaissance Technologies | 425,179 | $1,212 | 0.00% |
| Handelsbanken Fonder AB | 101,064 | $288 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,638 | $55,968 | 0.00% |
| Compagnie Lombard Odier SCmA | 10,000 | $28,500 | 0.00% |